HMEU:LSE:LSE-HSBC MSCI Europe UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 1522.1

Change

-6.90 (-0.45)%

Market Cap

USD 0.19B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-1.38 (-0.49%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

+1.00 (+1.42%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.60 (+1.21%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.19 (+1.37%)

USD 586.49B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.34 (+1.86%)

USD 586.49B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+28.50 (+1.37%)

USD 329.34B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.48%)

USD 266.08B
0QZO:LSE 0QZO

+0.20 (+0.21%)

USD 258.54B

ETFs Containing HMEU:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.41% 57% F 60% D-
Dividend Return 0.01% 17% F 14% F
Total Return 6.42% 56% F 59% D-
Trailing 12 Months  
Capital Gain 14.19% 57% F 61% D-
Dividend Return 0.03% 27% F 31% F
Total Return 14.22% 56% F 60% D-
Trailing 5 Years  
Capital Gain 24.78% 50% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.78% 47% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 6.34% 58% F 63% D
Dividend Return 6.36% 58% F 62% D
Total Return 0.01% 18% F 32% F
Risk Return Profile  
Volatility (Standard Deviation) 10.35% 64% D 78% C+
Risk Adjusted Return 61.38% 73% C 83% B
Market Capitalization 0.19B 54% F 40% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.